top of page
Who Are We_.png

GLCM Biosensor Platform

Advantages of the GLCM Biosensor Platform

GLCM is the first company to develop a repeatable and consistent electrochemical impedance spectroscopy (EIS) diagnostic biosensor – breakthrough technology

under-1-minute.png

EIS method does not require modification of biomolecules with fluorescent dyes, enzymes, redox or radioactive labels

under-1-minute.png

Precise results generated in under 1-minute (after assay)

under-1-minute.png

Non-Invasive collection method (saliva-based)

under-1-minute.png

Exceptional sensitivity and specificity that delivers the highest level of detection

under-1-minute.png

Early detection of virus with very high sensitivity

under-1-minute.png

Platform technology, tailorable for the detection of multiple pathogens

under-1-minute.png

Cost-effective and scalable - much greater accuracy than rapid tests - more cost effective than traditional RT-PCR tests

under-1-minute.png

Point of Care - Testing & Results
Point of Need
Deployable to remote areas

under-1-minute.png

Capable of data capture and reporting via AI cloud-based platform

under-1-minute.png

Capability to read multiple samples simultaneously, reducing the individual results time

Looking for More?

We are expanding the global economy. The GLCM Biosensor Platform technology is available to license and will be a monumental product for future generations.


Modular integrations allow our technology to communicate with microelectronics. This can be utilized for real-time updates and relaying data to human resource managers and health associations.


GLC Medical is currently seeking strategic partners and welcomes all inquiries and discussions relating to the advancement of this breakthrough detection technology.


For more information, please email us at glcmsolutions@glcplus.com

bottom of page